Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions... Show more
AORT's Aroon Indicator triggered a bullish signal on July 15, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 253 similar instances where the Aroon Indicator showed a similar pattern. In of the 253 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on July 09, 2025. You may want to consider a long position or call options on AORT as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 50-day moving average for AORT moved above the 200-day moving average on June 24, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for AORT moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where AORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AORT turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AORT broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.100) is normal, around the industry mean (24.469). AORT has a moderately high P/E Ratio (434.783) as compared to the industry average of (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.439) is also within normal values, averaging (42.883).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a provider of cryopreserved human tissue for vascular transplant applications
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ALTFX | 152.12 | N/A | N/A |
AB Sustainable Global Thematic A | |||
PRJBX | 45.85 | N/A | N/A |
PGIM Jennison Global Opportunities R2 | |||
FAPLX | 12.82 | N/A | N/A |
Fidelity Advisor Healthy Future M | |||
FCUIX | 19.62 | -0.18 | -0.91% |
NYLI PineStone U.S. Equity Class I | |||
PSSRX | 24.26 | -0.38 | -1.54% |
PGIM Jennison Financial Services R |
A.I.dvisor indicates that over the last year, AORT has been loosely correlated with SIBN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then SIBN could also see price increases.
Ticker / NAME | Correlation To AORT | 1D Price Change % | ||
---|---|---|---|---|
AORT | 100% | -1.55% | ||
SIBN - AORT | 47% Loosely correlated | -2.31% | ||
BSX - AORT | 46% Loosely correlated | -0.81% | ||
ITGR - AORT | 46% Loosely correlated | -1.70% | ||
TCMD - AORT | 43% Loosely correlated | -3.78% | ||
SONVY - AORT | 42% Loosely correlated | -0.73% | ||
More |